Treatment of cannabis use among people with psychotic or depressive disorders: A systemic review

Journal of Clinical Psychiatry

Volumn 71, Issue 3, 2010, Pages 247-254

  Baker, Amanda L ^a   Hides, Leanne ^b   Lubman, Dan I ^b  

^a UNIVERSITY OF NEWCASTLE   (Australia)

^b UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; OLANZAPINE; PLACEBO; RISPERIDONE;

ALCOHOLISM; BIPOLAR DISORDER; CANNABIS ADDICTION; CLINICAL TRIAL; COCAINE DEPENDENCE; COGNITIVE THERAPY; DEPRESSION; DRUG EFFICACY; HEROIN DEPENDENCE; HUMAN; MEDLINE; META ANALYSIS; MOOD DISORDER; PRIORITY JOURNAL; PSYCHOEDUCATION; PSYCHOPHARMACOLOGY; PSYCHOPHARMACOTHERAPY; PSYCHOSIS; PSYCINFO; REVIEW; SCHIZOAFFECTIVE PSYCHOSIS; SCHIZOPHRENIA; SYSTEMATIC REVIEW;

ADOLESCENT; ADULT; ANXIETY DISORDERS; COMORBIDITY; DEPRESSIVE DISORDER; HUMANS; INTERVIEWS AS TOPIC; MARIJUANA ABUSE; MOTIVATION; OUTCOME ASSESSMENT (HEALTH CARE); PSYCHOTHERAPY; PSYCHOTIC DISORDERS; PSYCHOTROPIC DRUGS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 77950337098     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: 10.4088/JCP.09r05119gry     Document Type: Review

References (36)

1. Degenhardt L, Hall W. The association between psychosis and problematical drug use among Australian adults: findings from the National Survey of Mental Health and Well-Being. Psychol Med. 2001;31(4): 659-668.
2. Degenhardt L, Hall W, Lynskey M. Alcohol, cannabis and tobacco use among Australians: a comparison of their associations with other drug use and use disorders, affective and anxiety disorders, and psychosis. Addiction. 2001;96(11):1603-1614.
3. Farrell M, Howes S, Bebbington P, et al. Nicotine, alcohol and drug dependence and psychiatric comorbidity: results of a national household survey. Br J Psychiatry. 2001;179(5):432-437.
4. Merikangas KR, Mehta RL, Molnar BE, et al. Comorbidity of substance use disorders with mood and anxiety disorders: results of the International Consortium in Psychiatric Epidemiology. Addict Behav. 1998;23(6):893-907.
5. Stinson FS, Ruan WI, Pickering R, et al. Cannabis use disorders in the USA: prevalence, correlates and co-morbidity. Psychol Med. 2006;36(10):1447- 1460.
6. Degenhardt L, Hall W, Lynskey M. The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Soc Psychiatry Psychiatr Epidemiol. 2001;36(5):219-227.
7. Mueser KT, Yarnold PR, Rosenberg SD, et al. Substance use disorder in hospitalized severely mentally ill psychiatric patients: prevalence, correlates, and subgroups. Schizophr Bull. 2000;26(1):179-192.
8. Lambert M, Conus P, Lubman DI, et al. The impact of substance use disorders on clinical outcome in 643 patients with first-episode psychosis. Acta Psychiatr Scand. 2005;112(2):141-148.
9. Ablon SL, Goodwin FK. High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients. Am J Psychiatry. 1974;131(4):448-453.
10. Mathew RJ, Wilson WH, Tant SR. Acute changes in cerebral blood flow associated with marijuana smoking. Acta Psychiatr Scand. 1989;79(2):118-128.
11. Hasin DS, Liu X, Nunes E, et al. Effects of major depression on remission and relapse of substance dependence. Arch Gen Psychiatry. 2002;59(4):375-380.
12. Degenhardt L, Tennant C, Gilmour S, et al. The temporal dynamics of relationships between cannabis, psychosis and depression among young adults with psychotic disorders: findings from a 10-month prospective study. Psychol Med. 2007;37(7):927-934.
13. Hides L, Dawe S, Kavanagh DJ, et al. Psychotic symptom and cannabis relapse in recent-onset psychosis: prospective study. Br J Psychiatry. 2006;189(2):137-143.
14. Linszen DH, Dingemans PM, Lenior ME. Cannabis abuse and the course of recent-onset schizophrenic disorders. Arch Gets Psychiatry. 1 994;51(4):273-279.
15. Zammit S, Moore THM, Lingford-Hughes A, et al. Effects of cannabis use on outcomes of psychotic disorders: systematic review. Br J Psychiatry. 2008;193(5):357-363.
16. Jablensky A, Sartorius N, Ernberg G, et al. Schizophrenia: manifestations, incidence and course in different cultures: a World Health Organization ten-country study. Psychol Med. 1991;20(suppl 20):1-97.
17. Akerele E, Levin FR. Comparison of olanzapine to risperidone in substance-abusing individuals with schizophrenia. Am J Addict. 2007;16(4):260-268.
18. Cornelius JR, Salloum IM, Haskett RF, et al. Fluoxetine versus placebo for the marijuana use of depressed alcoholics. Addict Behav. 1999;24(1):111-114.
19. Baker A, Lewin T, Reichler H, et al. Evaluation of a motivational interview for substance use within psychiatric in-patient services. Addiction. 2002;97(10):1329-1337.
20. Baker A, Lewin T, Reichler H, et al. Motivational interviewing among psychiatric in-patients with substance use disorders. Acta Psychiatr Scand. 2002;106(3):233-240.
21. Greig RL, Baker A, Lewin TJ, et al. Long-term follow-up of people with co-existing psychiatric and substance use disorders: patterns of use and outcomes. Drug Alcohol Rev. 2006;25(3):249-258.
22. Baker A, Bucci S, Lewin TJ, et al. Cognitive-behavioural therapy for substance use disorders in people with psychotic disorders: Randomised controlled trial. Br J Psychiatry. 2006;188(5):439-448.
23. Edwards J, Elkins K, Hinton M, et al. Randomized controlled trial of a cannabis-focused intervention for young people with first-episode psychosis. Acta Psychiatr Scand. 2006;114(2):109-117.
24. Martino S, Carroll KM, Nich C, et al. A randomized controlled pilot study of motivational interviewing for patients with psychotic and drug use disorders. Addiction. 2006;101(10):1479-1492.
25. Kay-Lambkin FJ, Baker AL, Lewin TJ, et al. Computer-based psychological treatment for comorbid depression and problematic alcohol and/or cannabis use a randomized controlled trial of clinical efficacy. Addiction. 2009;104(3):378-388.
26. Cleary M, Hunt G, Matheson S, et al. Psychosocial interventions for people with both severe mental illness and substance misuse. Cochrane Database Syst Rev. 2008;(1):CD001088.
27. Carroll KM, Easton CJ, Nich C, et al. The use of contingency management and motivational/skills-building therapy to treat young adults with marijuana dependence. J Consult Clin Psychol. 2006;74(5):955-966.
28. Marijuana Treatment Project Research Group. Brief treatments for cannabis dependence: findings from a randomized multisite trial. J Consult Clin Psychol. 2004;72(3):455-466.
29. Budney AJ, Moore BA, Rocha HL, et al. Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. J Consult Clin Psychol. 2006;74(2):307-316.
30. Dutra L, Stathopoulou G, Basden SL, et al. A meta-analytic review of psychosocial interventions for substance use disorders. Am J Psychiatry. 2008;165(2):179-187.
31. Bellack AS, Bennett ME, Gearon JS, et al. A randomized clinical trial of a new behavioral treatment for drug abuse in people with severe and persistent mental illness. Arch Gen Psychiatry. 2006;63(4):426-432.
32. Sigmon SC, Higgins ST. Voucher-based contingent reinforcement of marijuana abstinence among individuals with serious mental illness. J Subst Abuse Treat. 2006;30(4):291-295.
33. Kraemer HC, Wilson GT, Fairburn CG, et al. Mediators and moderators of treatment effects in randomized clinical trials. Arch Gen Psychiatry. 2002;59(10):877-883.
34. Litt MD, Kadden RM, Kabela-Cormier E, et al. Coping skills training and contingency management treatments for marijuana dependence: exploring mechanisms of behavior change. Addiction. 2008;103(4):638-648.
35. Litt MD, Kadden RM, Stephens RS; Marijuana Treatment Project Research Group. Coping and self-efficacy in marijuana treatment: results from the marijuana treatment project. J Consult Clin Psychol. 2005;73(6):1015-1025.
36. Morgenstern J, Longabaugh R. Cognitive-behavioral treatment for alcohol dependence: a review of evidence for its hypothesized mechanisms of action. Addiction. 2000;95(10):1475-1490.